Lisinopril Tablet
Product Images NDC 51655-994

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 51655-994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)

FDA Label Image

Label (51655 994 52 Master Bottle Label Approval Rev A 06 22)

Label (51655 994 52 Master Bottle Label Approval   Rev A 06 22)
This is a description of Lisinopril Tablets, USP with 20mg strength, NDC number 51655-994-52, and packaged with 30 tablets per container. It is a prescription drug and should be stored in its original container at a controlled room temperature range of 20° - 25°C (687 - 77°F), protected from moisture, freezing, and excessive heat. The package insert should be consulted for dosage instructions. The product is repackaged by Northwind Pharmaceuticals in Indianapolis, IN and each tablet contains Lisinopril USP, 20mg. There is a product code LOT and expiration date EXP listed on the packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.